Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuminori Abe

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Immunopharmacology|October 17, 2009
Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB miceFuminori Abe, Ibrahim Younos, Sherry Westphal, et al.
Journal of Clinical Biochemistry and Nutrition|September 22, 2015
Effects of 5-aminolevulinic acid on a murine model of diet-induced obesityMegumi Koganei, Yuri Saitou, Kyoko Tsuchiya, et al.
International Immunopharmacology|July 8, 2008
Evaluation of the ameliorative effects of immunosuppressants on crescentic glomerulonephritis in SCG/Kj miceKan Saiga, Minako Yoshida, Iwao Nakamura, et al.
Arthritis and Rheumatism|November 1, 2006
NK026680, a novel suppressant of dendritic cell function, prevents the development of rapidly progressive glomerulonephritis and perinuclear antineutrophil cytoplasmic antibody in SCG/Kj miceKan Saiga, Kazuhiro Tokunaka, Eiji Ichimura, et al.
American Journal of Physiology. Renal Physiology|August 2, 2013
5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injuryJiangang Hou, Songjie Cai, Yuya Kitajima, et al.
Molecular and Clinical Oncology|July 15, 2015
Plasma protoporphyrin IX following administration of 5-aminolevulinic acid as a potential tumor markerUrara Ota, Hideo Fukuhara, Masahiro Ishizuka, et al.
International Immunopharmacology|December 15, 2010
Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapyMasahiro Ishizuka, Fuminori Abe, Yuki Sano, et al.
Anticancer Research|June 20, 2013
Antitumor effect of combination of hyperthermotherapy and 5-aminolevulinic acid (ALA)Kiwamu Takahashi, Takeo Hasegawa, Takuya Ishii, et al.
BMC Research Notes|March 19, 2011
The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liverShun-Ichiro Ogura, Kouji Maruyama, Yuichiro Hagiya, et al.
Photodiagnosis and Photodynamic Therapy|September 11, 2012
Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitroYuichiro Hagiya, Yoshio Endo, Yutaka Yonemura, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Immunopharmacology|October 17, 2009
Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB miceFuminori Abe, Ibrahim Younos, Sherry Westphal, et al.
Journal of Clinical Biochemistry and Nutrition|September 22, 2015
Effects of 5-aminolevulinic acid on a murine model of diet-induced obesityMegumi Koganei, Yuri Saitou, Kyoko Tsuchiya, et al.
International Immunopharmacology|July 8, 2008
Evaluation of the ameliorative effects of immunosuppressants on crescentic glomerulonephritis in SCG/Kj miceKan Saiga, Minako Yoshida, Iwao Nakamura, et al.
Arthritis and Rheumatism|November 1, 2006
NK026680, a novel suppressant of dendritic cell function, prevents the development of rapidly progressive glomerulonephritis and perinuclear antineutrophil cytoplasmic antibody in SCG/Kj miceKan Saiga, Kazuhiro Tokunaka, Eiji Ichimura, et al.
American Journal of Physiology. Renal Physiology|August 2, 2013
5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injuryJiangang Hou, Songjie Cai, Yuya Kitajima, et al.
Molecular and Clinical Oncology|July 15, 2015
Plasma protoporphyrin IX following administration of 5-aminolevulinic acid as a potential tumor markerUrara Ota, Hideo Fukuhara, Masahiro Ishizuka, et al.
International Immunopharmacology|December 15, 2010
Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapyMasahiro Ishizuka, Fuminori Abe, Yuki Sano, et al.
Anticancer Research|June 20, 2013
Antitumor effect of combination of hyperthermotherapy and 5-aminolevulinic acid (ALA)Kiwamu Takahashi, Takeo Hasegawa, Takuya Ishii, et al.
BMC Research Notes|March 19, 2011
The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liverShun-Ichiro Ogura, Kouji Maruyama, Yuichiro Hagiya, et al.
Photodiagnosis and Photodynamic Therapy|September 11, 2012
Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitroYuichiro Hagiya, Yoshio Endo, Yutaka Yonemura, et al.
Pageof 3